LDS/Medical Tests/Glutathione, Total

Glutathione, Total

Glutathione is a tripeptide antioxidant composed of amino acids cysteine, glycine, and glutamate. Its synthesis occurs enzymatically via gamma-glutamyl cysteine synthase and glutathione synthase. Glutathione functions as a primary antioxidant, neutralizing reactive oxygen species (ROS) and maintaining cellular redox balance. It also regulates cytokine production, apoptosis, nutrient metabolism, and various immunological processes.

Glutathione is essential for maintaining erythrocyte membrane integrity and preventing oxidative damage. G6PD enzyme activity, crucial for NADPH regeneration, depends on sufficient levels of reduced glutathione. Inadequate glutathione availability leads to decreased NADPH reduction capacity, increased oxidative stress, and subsequent hemolysis. This scenario often arises from enzyme deficiencies or abnormal transcription of glutathione synthesizing enzymes, particularly glutathione reductase, gamma-glutamyl cysteine synthase, or glutathione synthase.

Glutathione deficiency can manifest as chronic hemolytic anemia, metabolic acidosis, and increased urinary excretion of 5-oxoproline. Notably, consumption of fava beans in individuals with glutathione or G6PD deficiency can trigger severe hemolytic episodes (favism). While low glutathione levels have clear clinical implications, elevated glutathione concentrations typically hold minimal clinical significance.

  • Evaluation and diagnosis of hemolytic anemia
  • As an aid the diagnosis of glutathione deficiency
  • Assessment of enzymatic activity of gamma-glutamyl cysteine synthase and glutathione synthase

Decreased Levels
Indicate dysfunction of glutathione synthesis enzymes (gamma-glutamyl cysteine synthase and glutathione synthase). This reduction is associated with hemolytic anemia and increased susceptibility to oxidative stress.

Increased Levels
Generally, of uncertain clinical importance but may occur in neonates or conditions like riboflavin supplementation, 5’-nucleotidase deficiency, myelofibrosis, and lead poisoning.

46.9-90.1 mg/dL (applicable to patients ≥12 years old)

Kinetic spectrophotometry assay.

Whole blood, ACD (Yellow vial). 

Stability

  • Refrigerated: 7-14 days
CBC, peripheral blood smear, reticulocyte count, LDH, bilirubin, haptoglobin, G6PD, gamma-glutamyl cysteine synthase, glutathione synthase, direct antiglobulin test, hereditary hemolytic anemia gene mutation panel.
1-2 weeks.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login